Automation In Biopharma Industry Global Market Report 2025
상품코드:1824336
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
바이오의약품 산업 자동화 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 7.4%를 나타내 29억 2,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 데이터 무결성과 문서화 강화, 맞춤형 의료의 상승, 모듈식, 유연한 바이오공정 시설의 상승, 자동화 플랫폼의 진화, 바이오시밀러 수요 증가, 스마트 센서와 사물인터넷(iot)의 채용에 기인합니다. 예측 기간의 주요 동향으로는 로봇공학과 자동화기술의 진보, 싱글유스기술의 진보, 바이오공정에서의 인공지능의 통합, 공정분석기술(PAT)의 진보, 바이오의약품기업과 기술기업의 협동, 바이오의약품 자동화에 있어서의 지속가능성의 중시 등이 있습니다.
향후 5년간의 성장률 7.4%라고 하는 예측은 전회의 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 독일과 싱가포르에서 개발된 모듈형 클린룸 시스템 및 자동 충전 마감 장비의 가격을 상승시켜 생산 병목 현상과 생물학적 제제의 개발 비용을 증가시켜 미국 의약품 제조에 지장을 줄 수 있습니다. 또한 상호관세나 무역마찰·제한의 격화에 의한 세계경제·무역에 대한 악영향에 의해 그 영향은 보다 광범위하게 미칠 것으로 보입니다.
의약품 제조에서 로봇 도입 증가는 바이오의약품 산업 시장에서 자동화의 성장을 가속할 것으로 예측됩니다. 여기서 말하는 로봇이란, 의약품의 제조나 포장에 있어서 다양한 작업을 실시하는 첨단의 자동화 시스템이나 기계를 말합니다. 2차 포장, 인트라 물류, 실험실 자동화, 픽앤플레이스, 약국 공정 자동화, 맞춤형 의료 등 의약품 제조에서 여러 응용 분야에서 활용됩니다. 이를 통해 생산성 향상, 정확성 강화, 오염 위험 감소, 작업자 안전성 향상이 가능합니다. 예를 들어 2024년 9월 독일을 거점으로 하는 전문 비영리 단체인 국제 로봇 연맹은 유럽 제조업에서 산업용 로봇의 도입 대수가 9% 증가하여 과거 최고의 9만 2,393대에 달했다고 보고했습니다. 이 중 80%는 유럽연합(EU) 역내에 설치되어 총 설치 대수는 7만 3,534대(전년 대비 2% 증가)가 되었습니다. 이 때문에 의약품 제조에 있어서의 로봇 도입의 확대가 바이오의약품 산업 자동화의 확대를 촉진하는 것으로 보입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 바이오의약품 산업 자동화 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 바이오의약품 산업 자동화 시장 : 성장률 분석
세계의 바이오의약품 산업 자동화 시장 실적 : 규모와 성장(2019-2024년)
세계의 바이오의약품 산업 자동화 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 바이오의약품 산업 자동화 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 바이오의약품 산업 자동화 시장 : 기술별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
자동화 기술
디지털화 기술
세계의 바이오의약품 산업 자동화 시장 : 구성 요소별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
자동화 하드웨어
자동화 소프트웨어
서비스 프로젝트 단계
서비스 운영 단계
세계의 바이오의약품 산업 자동화 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
임상 단계
신약 개발 단계
생산 단계
세계의 바이오의약품 산업 자동화 시장 : 자동화 기술 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
공정 자동화
실험실 자동화
로봇 공학 및 인공지능
제어 시스템
프로그래머블 로직 컨트롤러(PLC)
세계의 바이오의약품 산업 자동화 시장 : 디지털화 기술 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
데이터 분석 및 시각화
전자 실험실 노트(ELN)
클라우드 컴퓨팅
제약 산업의 사물인터넷(IoT)
디지털 트윈 기술
제7장 지역별/국가별 분석
세계의 바이오의약품 산업 자동화 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 바이오의약품 산업 자동화 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
바이오의약품 산업 자동화 시장 : 경쟁 구도
바이오의약품 산업의 자동화 시장 : 기업 프로파일
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Danaher Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
ABB Ltd : 개요, 제품 및 서비스, 전략 및 재무 분석
Siemens Healthineers AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Emerson Electric Co.
Becton Dickinson and Company(BD)
Corning Incorporated
Rockwell Automation Inc.
Agilent Technologies Inc.
PerkinElmer Inc.
Sartorius AG
bioMerieux SA
Mettler-Toledo International Inc.
Beckman Coulter Inc.
Waters Corporation
Pall Corporation
Bruker Corporation
Qiagen NV
Eppendorf AG
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
바이오의약품 산업 자동화 시장(2029년) : 새로운 기회를 제공하는 국가
바이오의약품 산업 자동화 시장(2029년) : 새로운 기회를 제공하는 부문
바이오의약품 산업 자동화 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Automation within the biopharma industry involves the incorporation of advanced technologies and robotics across different stages of the biopharmaceutical manufacturing process. This entails utilizing automated systems and equipment to execute tasks that were conventionally handled by humans, with the aim of enhancing efficiency, precision, and overall productivity in the production of biopharmaceutical products.
The principal technologies driving automation in the biopharma industry encompass automation technology and digitization technology. Automation technology encompasses the utilization of diverse technologies, such as robotics, artificial intelligence (AI), and software systems, to automate and streamline processes and tasks that were traditionally carried out by humans. This includes various components such as automation hardware, automation software, service project phases, and service operation phases, with applications spanning clinical phases, drug discovery phases, and production phases.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The automation in biopharma industry research report is one of a series of new reports from The Business Research Company that provides automation in biopharma industry market statistics, including the automation in biopharma industry's global market size, regional shares, competitors with a automation in biopharma industry market share, detailed automation in biopharma industry market segments, market trends and opportunities, and any further data you may need to thrive in the automation in biopharma industry. This automation in the biopharma industry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The automation in biopharma industry market size has grown strongly in recent years. It will grow from $2.08 billion in 2024 to $2.19 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increased complexity in biopharmaceutical processes, need for improved process efficiency, growth in biologics development and manufacturing, demand for quality assurance and control, pressure to reduce time-to-market.
The automation in biopharma industry market size is expected to see strong growth in the next few years. It will grow to $2.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to enhanced data integrity and documentation, rise of personalized medicine, rise of modular and flexible bioprocessing facilities, evolution of automation platforms, rising demand for biosimilars, adoption of smart sensors and internet of things (iot). Major trends in the forecast period include advances in robotics and automation technologies, advancements in single-use technologies, integration of artificial intelligence in bioprocessing, advances in process analytical technologies (pat), collaboration between biopharma and technology companies, emphasis on sustainability in biopharma automation.
The forecast of 7.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. drug manufacturing by inflating prices of modular cleanroom systems and automated fill-finish equipment developed in Germany and Singapore, resulting in production bottlenecks and higher biologic drug development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising adoption of robots in pharmaceutical manufacturing is expected to drive the growth of automation in the biopharma industry market. Robots in this context refer to advanced automated systems and machines that carry out various tasks in the production and packaging of pharmaceutical products. They are utilized across multiple applications in pharmaceutical manufacturing, including secondary packaging, intralogistics, laboratory automation, pick and place, pharmacy process automation, and personalized medicine. This leads to greater productivity, enhanced precision, reduced contamination risks, and improved worker safety. For instance, in September 2024, the International Federation of Robotics, a Germany-based professional non-profit organization, reported that industrial robot installations in the manufacturing sector in Europe rose by 9%, reaching a record high of 92,393 units. Of these, 80% were installed within the European Union, totaling 73,534 units-a 2% increase from the previous year. Therefore, the growing adoption of robots in pharmaceutical manufacturing will drive the expansion of automation in the biopharma industry market.
The growth of automation in the biopharma industry market is further expected to be fueled by the increasing pace of drug development. The process of drug development involves the discovery and introduction of new pharmaceutical products to the market. As drug development intensifies, the automation of processes becomes essential within the biopharma industry. Automated systems play a crucial role in streamlining processes, expediting research, ensuring precision, and enhancing overall efficiency. For example, in 2022, the Center for Drug Evaluation and Research (CDER) granted approval to 37 new drugs, categorized as novel drugs, with 54% of them receiving approval in the same year. Hence, the surge in drug development activities acts as a catalyst for the growth of automation in the biopharma industry market.
A prominent trend in the automation in the biopharma industry market is the adoption of technological advancements by major companies. These companies are actively engaged in developing advanced product technologies to fortify their positions in the market. An illustration of this trend is observed in the actions of PerkinElmer Inc., a US-based company providing scientific solutions and technologies. In September 2022, PerkinElmer Inc. introduced the Cellaca PLX Image Cytometry System, an advanced automated cell analysis solution designed to simplify cell and gene therapy research and manufacturing. This platform enables researchers to assess critical quality attributes of cell samples, including identity, quantity, and quality, through an automated workflow. The integrated system encompasses image cytometer hardware, software, validated consumables, and trackable data reporting, streamlining calibration and training requirements.
Major companies in the automation in biopharma industry market are actively developing advanced technologies, including automated customer data platforms (CDP)To cater to a larger customer base, boost sales, and increase revenue. An automated CDP is a software solution designed to automatically collect, organize, and analyze customer data from diverse sources in a centralized manner. For instance, Tealium, a US-based provider of customer data orchestration tools, launched Tealium for Pharma in July 2022. This verticalized platform is meticulously crafted to fully automate and enhance the customer experience for Pharma audiences, addressing the challenges posed by dynamic privacy and security regulations in the industry. Tealium's data-first offering integrates and automates data seamlessly, resulting in an elevated customer experience while adhering to the highest standards of Health Insurance Portability and Accountability Act (HIPAA) compliance.
In April 2022, Bruker Corporation, a US-based company specializing in scientific instruments for molecular and materials research, acquired Optimal Industrial Automation Limited for an undisclosed amount. This acquisition positions Bruker as a key provider of software and solutions for small molecule, biologic, and new drug modalities in pharma companies. Optimal Industrial Automation Limited, based in the UK, offers pharmaceutical and biopharmaceutical automation solutions, including process analytical technology (PAT), manufacturing automation, quality assurance (QA) software, and systems integration.
Major companies operating in the automation in biopharma industry market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMerieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.
North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the automation in biopharma industry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The automation in biopharma industry market consists of revenues earned by entities by providing high-throughput screening, sample management, and cell culture automation used during the process. The market value includes the value of related goods sold by the service provider or included within the service offering. The automation in biopharma industry market also includes sales of automated dissolution testing systems, robotic sample storage and retrieval systems, and chromatography systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Automation In Biopharma Industry Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on automation in biopharma industry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for automation in biopharma industry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automation in biopharma industry market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Technology: Automation Technology; Digitization Technology
3) By Application: Clinical Phase; Drug Discovery Phase; Production Phase
Subsegments:
1) By Automation Technology: Process Automation; Laboratory Automation; Robotics And Artificial Intelligence; Control Systems; Programmable Logic Controllers (PLCs)
2) By Digitization Technology: Data Analytics And Visualization; Electronic Lab Notebooks (ELN); Cloud Computing; Internet Of Things (IoT) In Pharma; Digital Twin Technology
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Danaher Corporation; ABB Ltd; Siemens Healthineers AG; Emerson Electric Co.; Becton Dickinson and Company (BD); Corning Incorporated; Rockwell Automation Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; Sartorius AG; bioMerieux SA; Mettler-Toledo International Inc.; Beckman Coulter Inc.; Waters Corporation; Pall Corporation; Bruker Corporation; Qiagen N.V.; Eppendorf AG; Tecan Group Ltd.; Promega Corporation; Brooks Automation Inc.; Omron Automation; Hamilton Company; Integra Biosciences AG; Gilson Inc.; Analytik Jena AG; BioTek Instruments Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Automation In Biopharma Industry Market Characteristics
3. Automation In Biopharma Industry Market Trends And Strategies
4. Automation In Biopharma Industry Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Automation In Biopharma Industry Growth Analysis And Strategic Analysis Framework
5.1. Global Automation In Biopharma Industry PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Automation In Biopharma Industry Market Growth Rate Analysis
5.4. Global Automation In Biopharma Industry Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Automation In Biopharma Industry Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Automation In Biopharma Industry Total Addressable Market (TAM)
6. Automation In Biopharma Industry Market Segmentation
6.1. Global Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Automation Technology
Digitization Technology
6.2. Global Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Automation Hardware
Automation Software
Services Project Phase
Services Operation Phase
6.3. Global Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Phase
Drug Discovery Phase
Production Phase
6.4. Global Automation In Biopharma Industry Market, Sub-Segmentation Of Automation Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Process Automation
Laboratory Automation
Robotics And Artificial Intelligence
Control Systems
Programmable Logic Controllers (PLCs)
6.5. Global Automation In Biopharma Industry Market, Sub-Segmentation Of Digitization Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Analytics And Visualization
Electronic Lab Notebooks (ELN)
Cloud Computing
Internet Of Things (IoT) In Pharma
Digital Twin Technology
7. Automation In Biopharma Industry Market Regional And Country Analysis
7.1. Global Automation In Biopharma Industry Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Automation In Biopharma Industry Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Automation In Biopharma Industry Market
8.1. Asia-Pacific Automation In Biopharma Industry Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Automation In Biopharma Industry Market
9.1. China Automation In Biopharma Industry Market Overview
9.2. China Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Automation In Biopharma Industry Market
10.1. India Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Automation In Biopharma Industry Market
11.1. Japan Automation In Biopharma Industry Market Overview
11.2. Japan Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Automation In Biopharma Industry Market
12.1. Australia Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Automation In Biopharma Industry Market
13.1. Indonesia Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Automation In Biopharma Industry Market
14.1. South Korea Automation In Biopharma Industry Market Overview
14.2. South Korea Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Automation In Biopharma Industry Market
15.1. Western Europe Automation In Biopharma Industry Market Overview
15.2. Western Europe Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Automation In Biopharma Industry Market
16.1. UK Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Automation In Biopharma Industry Market
17.1. Germany Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Automation In Biopharma Industry Market
18.1. France Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Automation In Biopharma Industry Market
19.1. Italy Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Automation In Biopharma Industry Market
20.1. Spain Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Automation In Biopharma Industry Market
21.1. Eastern Europe Automation In Biopharma Industry Market Overview
21.2. Eastern Europe Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Automation In Biopharma Industry Market
22.1. Russia Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Automation In Biopharma Industry Market
23.1. North America Automation In Biopharma Industry Market Overview
23.2. North America Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Automation In Biopharma Industry Market
24.1. USA Automation In Biopharma Industry Market Overview
24.2. USA Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Automation In Biopharma Industry Market
25.1. Canada Automation In Biopharma Industry Market Overview
25.2. Canada Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Automation In Biopharma Industry Market
26.1. South America Automation In Biopharma Industry Market Overview
26.2. South America Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Automation In Biopharma Industry Market
27.1. Brazil Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Automation In Biopharma Industry Market
28.1. Middle East Automation In Biopharma Industry Market Overview
28.2. Middle East Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Automation In Biopharma Industry Market
29.1. Africa Automation In Biopharma Industry Market Overview
29.2. Africa Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Automation In Biopharma Industry Market Competitive Landscape And Company Profiles
30.1. Automation In Biopharma Industry Market Competitive Landscape
30.2. Automation In Biopharma Industry Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.4. ABB Ltd Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
31. Automation In Biopharma Industry Market Other Major And Innovative Companies
31.1. Emerson Electric Co.
31.2. Becton Dickinson and Company (BD)
31.3. Corning Incorporated
31.4. Rockwell Automation Inc.
31.5. Agilent Technologies Inc.
31.6. PerkinElmer Inc.
31.7. Sartorius AG
31.8. bioMerieux SA
31.9. Mettler-Toledo International Inc.
31.10. Beckman Coulter Inc.
31.11. Waters Corporation
31.12. Pall Corporation
31.13. Bruker Corporation
31.14. Qiagen N.V.
31.15. Eppendorf AG
32. Global Automation In Biopharma Industry Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Automation In Biopharma Industry Market
34. Recent Developments In The Automation In Biopharma Industry Market
35. Automation In Biopharma Industry Market High Potential Countries, Segments and Strategies
35.1 Automation In Biopharma Industry Market In 2029 - Countries Offering Most New Opportunities
35.2 Automation In Biopharma Industry Market In 2029 - Segments Offering Most New Opportunities
35.3 Automation In Biopharma Industry Market In 2029 - Growth Strategies
